Skip to content

Once-daily Kaletra approved in the European Union

Boosted protease inhibitor regimens with 3TC work despite M184V resistance

Maturation inhibitor bevirimat is well tolerated and effective in predicted responders

Mental health and HIV: a clinical review

Mental health and HIV: a clinical review

GSK's second integrase inhibitor looks potent and well-tolerated in early study

Number of UK gay men ever tested rises to two-thirds

Nutritional formula linked to reduced CD4 cell loss in untreated people

Pregnancy registry shows no evidence that tenofovir causes birth defects

IL-7 may boost CD4 and CD8 T-cells, study shows